|
|
Volumn 9, Issue 8, 2010, Pages 581-582
|
|
China spurs pharma innovation
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
CHINA;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
ECONOMIC DEVELOPMENT;
GOOD LABORATORY PRACTICE;
GOVERNMENT REGULATION;
HEALTH CARE POLICY;
INVESTMENT;
LICENSING;
NATIONAL HEALTH INSURANCE;
PATENT;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
SHORT SURVEY;
BIOTECHNOLOGY;
CHINA;
DRUG DESIGN;
DRUG DISCOVERY;
DRUG INDUSTRY;
GOVERNMENT AGENCIES;
HUMANS;
INTELLECTUAL PROPERTY;
RESEARCH;
|
|
EID: 77955133384
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3238 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|